Method development and validation for the analysis of a new anti-cancer infusion solution via HPLC

A fast and simple HPLC method has been developed and validated for the quantification of a completely new anti-cancer drug during the manufacturing process. The combination of four compounds including α-ketoglutaric acid, hydroxymethylfurfural, N-acetyl-L-methionine and N-acetyl-L-selenomethionine,...

Full description

Saved in:
Bibliographic Details
Published inJournal of separation science Vol. 34; no. 2; pp. 135 - 141
Main Authors Donnarumma, Fabrizio, Schober, Margot, Greilberger, Joachim, Matzi, Veronika, Lindenmann, Jörg, Maier, Alfred, Herwig, Ralf, Wintersteiger, Reinhold
Format Journal Article
LanguageEnglish
Published Weinheim Wiley-VCH Verlag 01.01.2011
WILEY-VCH Verlag
WILEY‐VCH Verlag
Wiley
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A fast and simple HPLC method has been developed and validated for the quantification of a completely new anti-cancer drug during the manufacturing process. The combination of four compounds including α-ketoglutaric acid, hydroxymethylfurfural, N-acetyl-L-methionine and N-acetyl-L-selenomethionine, administered intravenously, is still in test phase but has already shown promising results in cancer therapy. HPLC separation was achieved on an RP-18 column with a gradient system. However, the highly different concentrations of the compounds required a variation in the detection wavelength within one run. In order to produce a chromatogram where peaks were comparable on a similar range scale, detection at absorption maxima for the two most concentrated components was avoided. After optimization of the gradient program it was possible to detect all four substances within 14 min in spite of their strongly different chemical structure. The method developed was validated for accuracy, repeatability, reproducibility and robustness in relation to temperature and pH of buffer. Linearity as well as the limit of detection and quantification were determined. This HPLC method was found to be precise, accurate and reproducible and can be easily used for in-line process control during the manufacture of the anti-tumour infusion solution.
Bibliography:http://dx.doi.org/10.1002/jssc.201000574
C.Y.L. Pharmazeutika GmbH
ArticleID:JSSC201000574
istex:2DD068A301EC3CCBF4FF442898DBC6F6532A4D1C
ark:/67375/WNG-95D4KDXG-B
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1615-9306
1615-9314
1615-9314
DOI:10.1002/jssc.201000574